3-Hydrazinylpyridine hydrochloride → 3-(1,1-difluoroethyl)-1-(pyridin-3-yl)-1H-pyrazol-5-amine
Reaction equation
Cl.[NH:2]([C:4]1[CH:5]=[N:6][CH:7]=[CH:8][CH:9]=1)[NH2:3].[F:10][C:11]([F:18])([CH3:17])[C:12](=O)[CH2:13][C:14]#[N:15]>>[F:10][C:11]([C:12]1[CH:13]=[C:14]([NH2:15])[N:2]([C:4]2[CH:5]=[N:6][CH:7]=[CH:8][CH:9]=2)[N:3]=1)([F:18])[CH3:17]Participants
3
Procedure
3-Hydrazinopyridine hydrochloride (435 mg, 3.0 mmol) was treated with 4,4-difluoro-3-oxopentanenitrile (400 mg, 3.0 mmol) (prepared as described in Example 152A Step 1) according to the procedure in Example 161A Step 3 to afford 3-(1,1-difluoroethyl)-1-(pyridin-3-yl)-1H-pyrazol-5-amine (62 mg, 0.27 mmol, 9%). 1H NMR (300 MHz, MeOD) δ 8.86 (s, 1H), 8.60 (d, 1H), 8.12 (d, 1H), 7.62 (t, 1H), 5.82 (s, 1H), 1.92 (t, 3H); LC-MS (ESI) m/z 225 (M+H)+.
Sources & evidence
- ORD record
- ord-08b2344ccb8b483c8be2d2d1a7a33d17
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08969587B2
Reaction notes
Loading…